We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.15B
AUM Growth
+$59M
Cap. Flow
-$87.2M
Cap. Flow %
-7.58%
Top 10 Hldgs %
12.78%
Holding
1,132
New
384
Increased
172
Reduced
194
Closed
306

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Healthcare 10.04%
3 Consumer Discretionary 6.7%
4 Real Estate 4.77%
5 Communication Services 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QGEN icon
651
Qiagen
QGEN
$8.55B
$237K 0.02%
+6,611
New +$246K
CASA
652
DELISTED
Casa Systems, Inc. Common Stock
CASA
$235K 0.02%
+57,475
New +$274K
SJI
653
DELISTED
South Jersey Industries, Inc.
SJI
$235K 0.02%
7,117
-3,343
-32% -$105K
BRPM.U
654
DELISTED
B. Riley Principal Merger Corp.
BRPM.U
$235K 0.02%
+22,426
New +$229K
BALL icon
655
Ball Corp
BALL
$17.4B
$234K 0.02%
+3,617
New +$245K
XLNX
656
DELISTED
Xilinx Inc
XLNX
$232K 0.02%
2,368
-2,138
-47% -$201K
LX
657
CALL
LexinFintech Holdings
LX
$246M
$229K 0.02%
+165
New +$1.89K
SLDB icon
658
CALL
Solid Biosciences
SLDB
$836M
$227K 0.02%
34
-3
-8% -$331
KLR
659
DELISTED
Kaleyra, Inc.
KLR
$227K 0.02%
+7,645
New +$254K
BW icon
660
Babcock & Wilcox
BW
$1.41B
$226K 0.02%
61,985
KRTX
661
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$226K 0.02%
+3,000
New +$131K
CWEN icon
662
Clearway Energy Class C
CWEN
$4.94B
$225K 0.02%
+11,283
New +$218K
MBIO icon
663
Mustang Bio
MBIO
$4.5M
$225K 0.02%
+73
New +$167K
REI icon
664
Ring Energy
REI
$315M
$225K 0.02%
+85,204
New +$167K
SHOE
665
Shoe Station Group
SHOE
$420M
$225K 0.02%
+12,066
New +$213K
VKTX icon
666
CALL
Viking Therapeutics
VKTX
$3.86B
$225K 0.02%
+281
New +$2.05K
VKTX icon
667
PUT
Viking Therapeutics
VKTX
$3.86B
$225K 0.02%
+281
New +$2.05K
XPO icon
668
XPO
XPO
$23.4B
$225K 0.02%
8,162
-376
-4% -$10.3K
SPLK
669
CALL
DELISTED
Splunk Inc
SPLK
$225K 0.02%
+15
New +$1.97K
RPLA.WS
670
DELISTED
Replay Acquisition Corp. Warrants
RPLA.WS
$225K 0.02%
+22,434
New +$16.7K
PBFS icon
671
Pioneer Bancorp
PBFS
$442M
$224K 0.02%
+14,642
New +$198K
IQV icon
672
IQVIA
IQV
$39.1B
$223K 0.02%
+1,443
New +$211K
AKRO
673
DELISTED
Akero Therapeutics
AKRO
$222K 0.02%
+10,000
New +$207K
AIMT
674
DELISTED
Aimmune Therapeutics
AIMT
$222K 0.02%
6,640
-19,360
-74% -$541K
DBVT
675
DBV Technologies
DBVT
$817M
$221K 0.02%
+2,066
New +$165K

Similar funds

Boothbay Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Boothbay Fund Management held 1,132 positions worth $1.15B, up 5.4% from $1.09B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $87.2M in Q4 2019, closing 306 positions and reducing 194 holdings. Its most notable exit was Celgene Corp, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00 worth $9.4M.

  • Boothbay Fund Management's largest Q4 2019 buy was Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00: 949,000 shares worth $9.4M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q4 2019, an estimated $12.8M increase.
  • Boothbay Fund Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $15.9M.
  • Boothbay Fund Management fully exited Celgene Corp in Q4 2019, selling an estimated $15M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $1.15B portfolio in Q4 2019.
  • Boothbay Fund Management opened 384 new positions and closed 306 in Q4 2019.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $1.15B.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.